Description
Specificity and affinity towards a given ligand/epitope limit target-specific delivery. Companies can spend between $500 million to $2 billion attempting to discover a new drug or therapy; a significant portion of this expense funds high-throughput screening to find the most successful target-specific compound available.
Copyright Statement
Download count: 0
Details
Contributors
- Marsh, William (Author)
- Stabenfeldt, Sarah (Thesis advisor)
- Caplan, Michael (Committee member)
- Sierks, Michael (Committee member)
- Arizona State University (Publisher)
Date Created
The date the item was original created (prior to any relationship with the ASU Digital Repositories.)
2013
Subjects
Resource Type
Collections this item is in
Note
- Partial requirement for: M.S., Arizona State University, 2013Note typethesis
- Includes bibliographical references (p. 41-44)Note typebibliography
- Field of study: Bioengineering
Citation and reuse
Statement of Responsibility
by William Marsh